245 related articles for article (PubMed ID: 15280932)
1. Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation.
Milano G; Ferrero JM; François E
Br J Cancer; 2004 Aug; 91(4):613-7. PubMed ID: 15280932
[TBL] [Abstract][Full Text] [Related]
2. The oral fluoropyrimidines in cancer chemotherapy.
Lamont EB; Schilsky RL
Clin Cancer Res; 1999 Sep; 5(9):2289-96. PubMed ID: 10499595
[TBL] [Abstract][Full Text] [Related]
3. The oral fluorinated pyrimidines.
de Bono JS; Twelves CJ
Invest New Drugs; 2001; 19(1):41-59. PubMed ID: 11291832
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
5. Novel oral chemotherapy agents.
Royce ME; Hoff PM; Pazdur R
Curr Oncol Rep; 2000 Jan; 2(1):31-7. PubMed ID: 11122822
[TBL] [Abstract][Full Text] [Related]
6. Oral fluoropyrimidines: are they the equivalent of parenteral infusional 5-fluorouracil?
Lokich J
Cancer Invest; 2001; 19(8):854-7. PubMed ID: 11768039
[No Abstract] [Full Text] [Related]
7. Oral therapy for colorectal cancer: how to choose.
Damjanov N; Meropol NJ
Oncology (Williston Park); 2000 Jun; 14(6):799-807; discussion 807-8, 813-4,. PubMed ID: 10887632
[TBL] [Abstract][Full Text] [Related]
8. Oral fluoropyrimidine treatment of colorectal cancer.
Eng C; Kindler HL; Schilsky RL
Clin Colorectal Cancer; 2001 Aug; 1(2):95-103. PubMed ID: 12445367
[TBL] [Abstract][Full Text] [Related]
9. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Cunningham D; Coleman R
Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
[TBL] [Abstract][Full Text] [Related]
10. Oral DPD-inhibitory fluoropyrimidine drugs.
Diasio RB
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):19-23. PubMed ID: 11098485
[TBL] [Abstract][Full Text] [Related]
11. UFT: mechanism of drug action.
Köhne CH; Peters GJ
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):13-8. PubMed ID: 11098484
[TBL] [Abstract][Full Text] [Related]
12. Oral fluoropyrimidines: a closer look at their toxicities.
Macdonald JS
Am J Clin Oncol; 1999 Oct; 22(5):475-80. PubMed ID: 10521062
[TBL] [Abstract][Full Text] [Related]
13. [Oral fluoropyrimidines in oncology].
González Barón M
An R Acad Nac Med (Madr); 1998; 115(3):721-45; discussion 745-6. PubMed ID: 10208021
[No Abstract] [Full Text] [Related]
14. Oral fluoropyrimidines in cancer treatment.
Lewis NL; Meropol NJ
Cancer Invest; 2000; 18(8):747-60. PubMed ID: 11107445
[No Abstract] [Full Text] [Related]
15. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
Iqbal S; Lenz HJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine: fulfilling the promise of oral chemotherapy.
Hwang JJ; Marshall JL
Expert Opin Pharmacother; 2002 Jun; 3(6):733-43. PubMed ID: 12036413
[TBL] [Abstract][Full Text] [Related]
17. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
Porschen R
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
[No Abstract] [Full Text] [Related]
18. Oral fluoropyrimidines in the treatment of colorectal cancer.
Meropol NJ
Eur J Cancer; 1998 Sep; 34(10):1509-13. PubMed ID: 9893621
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine in carcinoma of the pancreas.
Smith DB; Neoptolemos JP
Expert Opin Pharmacother; 2006 Aug; 7(12):1633-9. PubMed ID: 16872266
[TBL] [Abstract][Full Text] [Related]
20. Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.
Malet-Martino M; Martino R
Oncologist; 2002; 7(4):288-323. PubMed ID: 12185293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
